# US 2016/0355606 A1 · Anti-pcsk9 antibodies, formulations, dosing, and methods of use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355606 A1
- Document ID: US20160355606A1
- Status: Published application
- Kind: A1
- Application number: 14/981,853
- Filed: 2015-12-28
- Published: 2016-12-08
- Earliest claimed: 2012-06-15
- Assignees: Genentech, Inc.
- Applicants: Genentech, Inc.
- Inventors: Yan Wu; Cecilia Pui Chi Chiu; Daniel K. Kirchhofer; Andrew Peterson; Ganesh A. Kolumam; Monica Kong Beltran; Paul Moran; Wei Li; Xanthe Lam; Lin Luis; Ada Hui; Whittemore Tingley; John Douglas Davis; Nageshwar R. Budha
- Web page: https://patentgrep.com/patent/US20160355606A1

## CPC

- C07K 16/40: against enzymes
- A61K 39/39591: {Stabilisation, fragmentation}
- A61P 3/06: Antihyperlipidemics
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K 2039/505: {comprising antibodies}
- C07K 2317/34: Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
- C07K 2317/55: Fab or Fab'
- C07K 2317/76: Antagonist effect on antigen, e.g. neutralization or inhibition of binding
- C07K 2317/92: Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
- C07K 2317/94: Stability, e.g. half-life, pH, temperature or enzyme-resistance
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention provides anti-PCSK9 antibodies, formulations, dosing regimens, and methods of using the same.

## Claims

### Claim 1

An anti-PCSK9 antibody comprising a heavy chain and light chain variable domain comprising six hypervariable region (HVR) sequences:
(i) HVR-H1 comprising GFTFX1X2X3X4IH (SEQ ID NO:28), wherein X1 is S or T; X2 is G, R or S; X3 is H, T or Y; X4 is A or T;
(ii) HVR-H2 comprising RISPANGNTNYADSVKG (SEQ ID NO:4);
(iii) HVR-H3 comprising WIGSRELYIMDY (SEQ ID NO:5);
(iv) HVR-L1 comprising RASQDVSX1AVA (SEQ ID NO:29), wherein X1 is S or T;
(v) HVR-L2 comprising SASX1LYS (SEQ ID NO:30), wherein X1 is F or S; and
(vi) HVR-L3 comprising QQAYX1X2X3X4T (SEQ ID NO:37), wherein X1 is P, R or T; X2 is A, I, S or T; X3 is L, P or Q; X4 is A, H, P or S.

### Claim at position 2

2-100. (canceled)
